Uncategorized

The company named a new CFO and shared an update on its planned Inari Medical acquisition.

Intuitive Surgical will face competition this year from Medtronic and smaller companies like CMR Surgical and Moon Surgical coming to the U.S. market with robotic surgery systems.

Needham analysts, who were surprised by the bargain for Paragon 28, said Zimmer may not be done spending.

States and providers regained access to a key healthcare payments portal late Tuesday amid widespread backlash over the Trump administration’s decision to halt federal aid.

The layoffs follow an announcement in early January that I-Mab will re-prioritize resources to focus on advancing a CLDN18.2 and 4-1BB bispecific antibody for gastric cancers.

Although experts predict payers, providers and health technology companies will grapple with uncertainty in a second Trump administration, some hope that years-long headwinds could begin reversing course in 2025.

The move is part of a strategic restructuring aimed at getting azenosertib to the market for patients with gynecological malignancies.

The approval continues the trend of GLP-1s expanding to indications outside of diabetes and weight loss.

The discontinuation comes after the investigational drug, volenrelaxin, failed a related heart failure study in an overlapping patient population.

Site-neutral payment policy is a distraction from the underlying causes of high healthcare costs and places providers at risk, argues Ascension’s chief health outcomes officer.